{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:18:35Z","timestamp":1793215115497,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd012537","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T00:00:00Z","timestamp":1501632000000}}],"reference-count":75,"publisher":"Wiley","license":[{"start":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T00:00:00Z","timestamp":1501632000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T00:00:00Z","timestamp":1501632000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012537.pub2","type":"journal-article","created":{"date-parts":[[2017,8,3]],"date-time":"2017-08-03T09:37:33Z","timestamp":1501753053000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Non-steroidal anti-inflammatory drugs (NSAIDs) for chronic non-cancer pain in children and adolescents"],"prefix":"10.1002","author":[{"given":"Christopher","family":"Eccleston","sequence":"first","affiliation":[{"name":"University of Bath; Centre for Pain Research; Claverton Down Bath UK"},{"name":"Pain Research Unit, Churchill Hospital; Cochrane Pain, Palliative and Supportive Care Group; Oxford UK"},{"name":"Ghent University; Department of Clinical and Health Psychology; Ghent Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tess E","family":"Cooper","sequence":"additional","affiliation":[{"name":"The Children's Hospital at Westmead; Cochrane Kidney and Transplant, Centre for Kidney Research; Westmead NSW Australia 2145"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Fisher","sequence":"additional","affiliation":[{"name":"Pain Research Unit, Churchill Hospital; Cochrane Pain, Palliative and Supportive Care Group; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Anderson","sequence":"additional","affiliation":[{"name":"Starship Children\u2019s Hospital; Paediatric Intensive Care Unit; Park Road, Grafton Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick MR","family":"Wilkinson","sequence":"additional","affiliation":[{"name":"Evelina London Children's Hospital, Guys & St Thomas's NHS Foundation Trust; Westminster Bridge Road London UK SE1 7EH"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,8,2]]},"reference":[{"issue":"7","key":"10.1002\/14651858.CD012537.pub2-BIB0001|cit1","first-page":"276","article-title":"Double-blind study of ketoprofen and indomethacin in juvenile chronic arthritis","volume":"54","author":"Bhettay","year":"1978","journal-title":"South African Medical Journal"},{"issue":"1","key":"10.1002\/14651858.CD012537.pub2-BIB0002|cit2","first-page":"123","article-title":"Aspirin and fenoprofen (Nalfon) in the treatment of juvenile rheumatoid arthritis results of the double blind-trial. A segment II study","volume":"9","author":"Brewer","year":"1982","journal-title":"Journal of Rheumatology"},{"issue":"1","key":"10.1002\/14651858.CD012537.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3899\/jrheum.080073","article-title":"A prospective study comparing celecoxib with naproxen in children with juvenile rheumatoid arthritis","volume":"36","author":"Foeldvari","year":"2009","journal-title":"Journal of Rheumatology"},{"issue":"4","key":"10.1002\/14651858.CD012537.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0022-3476(05)80708-5","article-title":"Ibuprofen suspension in the treatment of juvenile rheumatoid arthritis","volume":"117","author":"Giannini","year":"1990","journal-title":"Journal of Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD012537.pub2-BIB0005|cit5","first-page":"79","article-title":"Naproxen in juvenile chronic polyarthritis","volume":"2","author":"Moran","year":"1979","journal-title":"European Journal of Rheumatology and Inflammation"},{"issue":"5","key":"10.1002\/14651858.CD012537.pub2-BIB0006|cit6","first-page":"985","article-title":"Evaluation of the comparative efficacy and tolerability of rofecoxib and naproxen in children and adolescents with juvenile rheumatoid arthritis: a 12-week randomized controlled clinical trial with a 52-week open-label extension","volume":"33","author":"Reiff","year":"2006","journal-title":"Journal of Rheumatology"},{"issue":"2","key":"10.1002\/14651858.CD012537.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/art.20860","article-title":"A randomized, double-blind clinical trial of two doses of meloxicam compared with naproxen in children with juvenile idiopathic arthritis","volume":"52","author":"Ruperto","year":"2005","journal-title":"Arthritis & Rheumatism"},{"issue":"1","key":"10.1002\/14651858.CD012537.pub2-BIB0008|cit8","first-page":"58","article-title":"A double-blind comparative study of the analgesic effects of fenbufen, codeine, aspirin, propoxyphene and placebo","volume":"19","author":"Coutinho","year":"1976","journal-title":"Current Therapeutic Research, Clinical and Experimental"},{"issue":"5","key":"10.1002\/14651858.CD012537.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S8756-3282(99)00203-3","article-title":"Treatment of childhood hypophosphatasia with nonsteroidal antiinflammatory drugs","volume":"25","author":"Girschick","year":"1999","journal-title":"Bone"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD012537.pub2-BIB0010|cit10","first-page":"28","article-title":"Tofranil in the treatment of low back pain","volume":"4","author":"Jenkins","year":"1976","journal-title":"Journal of International Medical Research"},{"issue":"2","key":"10.1002\/14651858.CD012537.pub2-BIB0011|cit11","first-page":"37","article-title":"Morning stiffness and nighttime pain in ankylosing spondylitis. A comparison between enteric-coated and plain naproxen tablets","volume":"12","author":"Johnsen","year":"1992","journal-title":"European Journal of Rheumatology and Inflammation"},{"issue":"3","key":"10.1002\/14651858.CD012537.pub2-BIB0012|cit12","first-page":"161","article-title":"Loxoprofen in the treatment of low back pain - clinical efficacy and safety in comparison to diclofenac","volume":"59","author":"Natour","year":"2002","journal-title":"Revista Brasileira de Medicina"},{"issue":"1","key":"10.1002\/14651858.CD012537.pub2-BIB0013|cit13","first-page":"105","article-title":"Results of the treatment of juvenile rheumatoid arthritis with indomethacine","volume":"42","author":"Reicher","year":"1969","journal-title":"Polskie Archiwum Medycyny Wewne\u0328trznej"},{"key":"10.1002\/14651858.CD012537.pub2-BIB0014|cit14","first-page":"11","article-title":"Azapropazone versus indomethacin in a double blind test with patients with ankylosing spondylitis","volume":"39","author":"Sadowska-Wroblewska","year":"1980","journal-title":"Zeitschrift fur Rheumatologie"},{"key":"10.1002\/14651858.CD012537.pub2-BIB0015|cit15","unstructured":"American Medical Association Pediatric pain management https:\/\/www.ama-assn.org\/"},{"key":"10.1002\/14651858.CD012537.pub2-BIB0016|cit16","unstructured":"Cochrane Pain Palliative and Supportive Care Group PaPaS author and referee guidance papas.cochrane.org\/papas-documents"},{"issue":"4","key":"10.1002\/14651858.CD012537.pub2-BIB0017|cit17","first-page":"259","article-title":"Hypersensitivity to nonsteroidal anti-inflammatory drugs in children and adolescents: cross-intolerance reactions","volume":"25","author":"Blanca-L\u00f3pez","year":"2015","journal-title":"Journal of Investigational Allergology & Clinical Immunology"},{"key":"10.1002\/14651858.CD012537.pub2-BIB0018|cit18","volume-title":"British National Formulary","author":"Joint Formulary Committee","year":"2016"},{"issue":"2","key":"10.1002\/14651858.CD012537.pub2-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/j.pain.0000000000000403","article-title":"A comprehensive categorical and bibliometric analysis of published research articles on pediatric pain from 1975 to 2010","volume":"157","author":"Caes","year":"2016","journal-title":"Pain"},{"issue":"7","key":"10.1002\/14651858.CD012537.pub2-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1474-4422(12)70134-5","article-title":"The role of the immune system in the generation of neuropathic pain","volume":"11","author":"Calvo","year":"2012","journal-title":"Lancet Neurology"},{"issue":"7","key":"10.1002\/14651858.CD012537.pub2-BIB0021|cit21","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012538.pub2","article-title":"Opioids for chronic non-cancer pain in children and adolescents","author":"Cooper","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD012537.pub2-BIB0022|cit22","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012535.pub2","article-title":"Antidepressants for chronic non-cancer pain in children and adolescents","author":"Cooper","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD012537.pub2-BIB0023|cit23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012563.pub2","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) for cancer-related pain in children and adolescents","author":"Cooper","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD012537.pub2-BIB0024|cit24","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012539.pub2","article-title":"Paracetamol (acetaminophen) for chronic non-cancer pain in children and adolescents","author":"Cooper","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012537.pub2-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"f2304","DOI":"10.1136\/bmj.f2304","article-title":"Influence of trial sample size on treatment effect estimates: meta-epidemiological study","volume":"346","author":"Dechartres","year":"2013","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012537.pub2-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1001\/jama.2014.8166","article-title":"Association between analytic strategy and estimates of treatment outcomes in meta-analyses","volume":"312","author":"Dechartres","year":"2014","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD012537.pub2-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD012537.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1136\/bmj.326.7404.1408","article-title":"Management of chronic pain in children and adolescents (editorial)","volume":"326","author":"Eccleston","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012537.pub2-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012537.pub2-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD012537.pub2-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jclinepi.2012.01.006","article-title":"Making an overall rating of the confidence in effect estimates for a single outcome and for all outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD012537.pub2-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jclinepi.2012.01.012","article-title":"GRADE guidelines: 12. Preparing summary of findings tables - binary outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD012537.pub2-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.neuroscience.2006.11.029","article-title":"Further characterization of a rat model of varicella zoster virus-associated pain: relationship between mechanical hypersensitivity and anxiety-related behavior, and the influence of analgesic drugs","volume":"144","author":"Hasnie","year":"2007","journal-title":"Neuroscience"},{"key":"10.1002\/14651858.CD012537.pub2-BIB0034|cit34","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"2","key":"10.1002\/14651858.CD012537.pub2-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.pain.2009.09.017","article-title":"How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy?","volume":"149","author":"Hoffman","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD012537.pub2-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S0736-0266(01)00114-0","article-title":"Epidural injection of cyclooxygenase-2 inhibitor attenuates pain-related behavior following application of nucleus pulposus to the nerve root in the rat","volume":"20","author":"Kawakami","year":"2002","journal-title":"Journal of Orthopaedic Research"},{"key":"10.1002\/14651858.CD012537.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7326\/0003-4819-107-2-224","article-title":"Meta-analysis in clinical research","volume":"107","author":"L'Abb\u00e9","year":"1987","journal-title":"Annals of Internal Medicine"},{"issue":"12","key":"10.1002\/14651858.CD012537.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1001\/jama.1995.03520360043037","article-title":"An assessment of the safety of pediatric ibuprofen","volume":"273","author":"Lesko","year":"1995","journal-title":"JAMA"},{"issue":"6","key":"10.1002\/14651858.CD012537.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1542\/peds.100.6.954","article-title":"Renal function after short-term ibuprofen use in infants and children","volume":"100","author":"Lesko","year":"1997","journal-title":"Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD012537.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1542\/peds.104.4.e39","article-title":"The safety of acetaminophen and ibuprofen among children younger than two years old","volume":"104","author":"Lesko","year":"1999","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD012537.pub2-BIB0041|cit41","volume-title":"An Evidence-based Resource for Pain Relief","author":"McQuay","year":"1998"},{"key":"10.1002\/14651858.CD012537.pub2-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"1153-9 e.1","DOI":"10.1016\/j.jpeds.2012.11.069","article-title":"Nonsteroidal anti-inflammatory drugs are an important cause of acute kidney injury in children","volume":"6","author":"Misurac","year":"2013","journal-title":"Journal of Pediatrics"},{"issue":"7","key":"10.1002\/14651858.CD012537.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"key":"10.1002\/14651858.CD012537.pub2-BIB0044|cit44","first-page":"15","article-title":"Managing potential publication bias","volume-title":"Systematic Reviews in Pain Research: Methodology Refined","author":"Moore","year":"2008"},{"issue":"3","key":"10.1002\/14651858.CD012537.pub2-BIB0045|cit45","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007076.pub2","article-title":"Pregabalin for acute and chronic pain in adults","author":"Moore","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD012537.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.pain.2010.05.011","article-title":"\"Evidence\" in chronic pain - establishing best practice in the reporting of systematic reviews","volume":"150","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD012537.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.pain.2010.02.039","article-title":"Fibromyalgia: moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD012537.pub2-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1136\/ard.2009.107805","article-title":"Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice","volume":"69","author":"Moore","year":"2010","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"3","key":"10.1002\/14651858.CD012537.pub2-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.pain.2010.07.2013","article-title":"Numbers-needed-to-treat analyses - do timing, dropouts, and outcome matter? Pooled analysis of two randomized, placebo-controlled chronic low back pain trials","volume":"151","author":"Moore","year":"2010","journal-title":"Pain"},{"key":"10.1002\/14651858.CD012537.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.pain.2009.08.007","article-title":"Clinical effectiveness: an approach to clinical trial design more relevant to clinical practice, acknowledging the importance of individual differences","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"5","key":"10.1002\/14651858.CD012537.pub2-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.pain.2010.11.030","article-title":"Minimum efficacy criteria for comparisons between treatments using individual patient meta-analysis of acute pain trials: examples of etoricoxib, paracetamol, ibuprofen, and ibuprofen\/paracetamol combinations after third molar extraction","volume":"152","author":"Moore","year":"2011","journal-title":"Pain"},{"issue":"6","key":"10.1002\/14651858.CD012537.pub2-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/EJA.0b013e328343c569","article-title":"Mean analgesic consumption is inappropriate for testing analgesic efficacy in post-operative pain: analysis and alternative suggestion","volume":"28","author":"Moore","year":"2011","journal-title":"European Journal of Anaesthesiology"},{"issue":"2","key":"10.1002\/14651858.CD012537.pub2-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.pain.2011.10.004","article-title":"Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses","volume":"153","author":"Moore","year":"2012","journal-title":"Pain"},{"issue":"4","key":"10.1002\/14651858.CD012537.pub2-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/anae.12148","article-title":"Pain measures and cut-offs - 'no worse than mild pain' as a simple, universal outcome","volume":"68","author":"Moore","year":"2013","journal-title":"Anaesthesia"},{"key":"10.1002\/14651858.CD012537.pub2-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"f2690","DOI":"10.1136\/bmj.f2690","article-title":"Expect analgesic failure; pursue analgesic success","volume":"346","author":"Moore","year":"2013","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD012537.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/papr.12050","article-title":"The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain","volume":"14","author":"Moore","year":"2014","journal-title":"Pain Practice"},{"issue":"1","key":"10.1002\/14651858.CD012537.pub2-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/j.1532-2149.2013.00341.x","article-title":"Duloxetine use in chronic painful conditions - individual patient data responder analysis","volume":"18","author":"Moore","year":"2014","journal-title":"European Journal of Pain"},{"key":"10.1002\/14651858.CD012537.pub2-BIB0058|cit58","unstructured":"National Institute of Health and Care Excellence (NICE) Guidance - sickle cell acute painful episode https:\/\/www.nice.org.uk\/guidance\/cg143\/evidence\/full-guideline-pdf-186634333"},{"key":"10.1002\/14651858.CD012537.pub2-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"c3515","DOI":"10.1136\/bmj.c3515","article-title":"Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study","volume":"341","author":"N\u00fcesch","year":"2010","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD012537.pub2-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1526-4637.2009.00685.x","article-title":"Patient-centered perspective on treatment outcomes in chronic pain","volume":"11","author":"O'Brien","year":"2010","journal-title":"Pain Medicine"},{"issue":"9","key":"10.1002\/14651858.CD012537.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jpain.2008.04.007","article-title":"Core outcome domains and measures for pediatric acute and chronic\/recurrent pain clinical trials: PedIMMPACT","volume":"9","author":"McGrath","year":"2008","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD012537.pub2-BIB0062|cit62","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"key":"10.1002\/14651858.CD012537.pub2-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.critrevonc.2008.12.005","article-title":"Pain therapy","volume":"70","author":"Ripamonti","year":"2008","journal-title":"Critical Reviews in Oncology\/Hematology"},{"issue":"1-2","key":"10.1002\/14651858.CD012537.pub2-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.pain.2006.05.006","article-title":"Systematic review of the psychometric properties, interpretability and feasibility of self-report pain intensity measures for use in clinical trials in children and adolescents","volume":"125","author":"Stinson","year":"2006","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD012537.pub2-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1365-2125.2008.03200.x","article-title":"Enriched enrolment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review","volume":"66","author":"Straube","year":"2008","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD012537.pub2-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/1471-2474-11-150","article-title":"Pregabalin in fibromyalgia - responder analysis from individual patient data","volume":"11","author":"Straube","year":"2010","journal-title":"BMC Musculoskeletal Disorders"},{"key":"10.1002\/14651858.CD012537.pub2-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2377-8-29","article-title":"Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials","volume":"8","author":"Sultan","year":"2008","journal-title":"BMC Neurology"},{"issue":"10","key":"10.1002\/14651858.CD012537.pub2-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"e25491","DOI":"10.1371\/journal.pone.0025491","article-title":"The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis - a simulation study","volume":"6","author":"Thorlund","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1002\/14651858.CD012537.pub2-BIB0069|cit69","unstructured":"United Nations World population prospects 2015 - population indicators esa.un.org\/unpd\/wpp\/Download\/Standard\/Population\/"},{"issue":"3","key":"10.1002\/14651858.CD012537.pub2-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.pain.2009.03.013","article-title":"Non-steroidal anti-inflammatory drugs for neuropathic pain: How do we explain continued widespread use?","volume":"143","author":"Vo","year":"2009","journal-title":"Pain"},{"issue":"1-2","key":"10.1002\/14651858.CD012537.pub2-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.pain.2006.08.014","article-title":"Systematic review of observational (behavioural) measures of pain for children and adolescents aged 3 to 18 years","volume":"127","author":"Baeyer","year":"2007","journal-title":"Pain"},{"key":"10.1002\/14651858.CD012537.pub2-BIB0072|cit72","volume-title":"WHO Guidelines on the Pharmacological Treatment of Persisting Pain in Children with Medical Illnesses","author":"World Health Organization","year":"2012"},{"issue":"7","key":"10.1002\/14651858.CD012537.pub2-BIB0073|cit73","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012564.pub2","article-title":"Opioids for cancer-related pain in children and adolescents","author":"Wiffen","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD012537.pub2-BIB0074|cit74","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012536.pub2","article-title":"Antiepileptic drugs for chronic non-cancer pain in children and adolescents","author":"Wiffen","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012537.pub2-BIB0075|cit75","unstructured":"World Bank Data - population ages 0-14 (% of total) data.worldbank.org\/indicator\/SP.POP.0014.TO.ZS"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD012537.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T23:08:00Z","timestamp":1628550480000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD012537.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,8,2]]},"references-count":75,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012537.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,2]]}}}